Full Breakdown
Conflation of Gender-Affirming Care and Female Genital Mutilation: A Legislative Battle in Connecticut
10/18/2025, 4:59:48 AM
Legislative Context and Core Conflict
Connecticut is one of the few states without a law explicitly banning female genital mutilation and cutting (FGM/C), a practice recognized as a severe form of gender-based violence. Advocates, including the Connecticut Coalition to End FGM/C, have sought to establish stronger state laws since 2020. However, recent legislative discussions have become contentious, particularly as they intersect with debates surrounding gender-affirming care for transgender youth. During a March 2025 judiciary committee hearing, confusion arose when some lawmakers conflated the proposed FGM/C ban with a ban on gender-affirming care, leading to a hostile environment for advocates like Mariya Taher, a survivor of FGM/C.
Federal Influence and Legislative Changes
The conflation of FGM/C and gender-affirming care has been exacerbated by actions from the Trump administration. Following an executive order in January 2025 that restricted gender-affirming care for minors, the administration began referring to such medical procedures as “chemical and surgical mutilation.” This rhetoric has been echoed by Republican lawmakers, including Rep. Marjorie Taylor Greene, who introduced the "Protect Children’s Innocence Act." This bill seeks to redefine FGM/C in federal law to include gender-affirming care, thereby threatening families seeking such treatments for their children.
Impact on Advocacy and Legislative Efforts
The backlash against gender-affirming care has hindered progress on FGM/C legislation. Although a bill to ban FGM/C passed unanimously out of committee, it was never brought to a full vote, as lawmakers hesitated to revisit the issue amid fears of it being weaponized against trans health care. Advocates like Kaitlin Mitchell from the U.S. End FGM/C Network have noted a decline in legislative support, attributing it to their visible support for the trans community. This shift has forced organizations to allocate resources towards educating lawmakers about the critical differences between FGM/C and medically necessary gender-affirming care.
Medical Community's Stance
The medical community, including the World Professional Association for Transgender Health (WPATH), emphasizes that gender-affirming care is evidence-based and involves extensive criteria for minors, contrasting sharply with FGM/C, which is nonconsensual and lacks medical justification. Dr. Marci Bowers, a leading figure in transgender health care, highlighted that surgeries for trans minors are rare and always conducted with informed consent, unlike FGM/C.
Criticism and Opposition
Critics argue that the conflation of these two issues undermines efforts to combat FGM/C and harms the trans community. Organizations like Sahiyo have condemned the administration's rhetoric and legislative proposals that equate gender-affirming care with mutilation. Sylvan Fraser Anthony from interACT, a nonprofit advocating for intersex rights, pointed out that Greene's bill also poses a threat to intersex individuals by allowing nonconsensual surgeries under certain conditions.
What's Next for Advocacy
As the Connecticut Coalition continues to push for comprehensive state legislation against FGM/C, advocates face a challenging landscape shaped by the intertwining of anti-trans rhetoric and gender-based violence issues. Rep. Jillian Gilchrest has committed to reintroducing the FGM/C bill in the next legislative session, but the ongoing conflation of these issues raises concerns about the future of both FGM/C advocacy and gender-affirming care access.
Verbatim Quotes
- “Intersex infants and young kids who are being subjected to these nonconsensual surgeries are suffering the exact harm that is being falsely claimed about gender-affirming care, and meanwhile, no one in the administration cares to do anything about it,” — Sylvan Fraser Anthony, Legal and Policy Director for interACT
- “We’re doing more and more work with less and less funding, and we’re having to put out all of these fires at the same time,” — Caitlin LeMay, Executive Director of the U.S. End FGM/C Network
This legislative battle underscores the complexities and challenges faced by advocates working to protect both the rights of trans individuals and the fight against FGM/C, revealing a critical intersection of gender, health care, and human rights.
